This page includes the latest FDA filings for Karyopharm Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | KPTI | DUNS 061317680 |
Device Company | Device | Date |
---|---|---|
Karyopharm Therapeutics Inc. | Prescription Medication | 2022-07-28 |
Karyopharm Therapeutics Inc. | Prescription Medication | 2022-04-07 |
Karyopharm Therapeutics Inc. | Prescription Medication | 2021-09-25 |
Karyopharm Therapeutics Inc. | Prescription Medication | 2021-05-20 |
Karyopharm Therapeutics Inc. | XPOVIO | 2021-05-19 |
Karyopharm Therapeutics Inc. | XPOVIO | 2021-05-19 |
Karyopharm Therapeutics Inc. | XPOVIO | 2021-05-19 |
Karyopharm Therapeutics Inc. | Prescription Medication | 2020-12-19 |
Karyopharm Therapeutics Inc. | Prescription Medication | 2020-09-16 |
Karyopharm Therapeutics Inc. | Prescription Medication | 2020-07-02 |
Karyopharm Therapeutics Inc. | Prescription Medication | 2019-08-21 |
Karyopharm Therapeutics Inc. | Prescription Medication | 2019-07-12 |
Karyopharm Therapeutics Inc. | XPOVIO | 2019-07-10 |
NCAGE Code | 7FSV2 | KARYOPHARM THERAPEUTICS INC.!DBA KARYOPHARM |
CAGE Code | 7FSV2 | KARYOPHARM THERAPEUTICS INC. KARYOPHARM |
S.A.M. Registration | 7FSV2 [61317680] | KARYOPHARM THERAPEUTICS INC. KARYOPHARM |
SEC | 0001503802 | Karyopharm Therapeutics Inc. of DELAWARE |